These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [The effect of a combination of ampicillin and sulbactam against clinical anaerobic isolates]. Werner H; Heizmann W; Heilmann F Arzneimittelforschung; 1988 Jul; 38(7):866-8. PubMed ID: 3207432 [TBL] [Abstract][Full Text] [Related]
44. In vitro activity of ampicillin plus sulbactam against anaerobes compared to ampicillin and cefoxitin. Heizmann W; Heilmann F; Werner H Infection; 1987; 15(5):370-4. PubMed ID: 3692611 [TBL] [Abstract][Full Text] [Related]
45. Comparison of the pharmacodynamic activity of cefotaxime plus metronidazole with cefoxitin and ampicillin plus sulbactam. Sullivan MC; Nightingale CH; Quintiliani R; Sweeney KR Pharmacotherapy; 1995; 15(4):479-86. PubMed ID: 7479201 [TBL] [Abstract][Full Text] [Related]
46. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina. Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852 [TBL] [Abstract][Full Text] [Related]
47. A multicentre study to evaluate the effect of sulbactam/ampicillin combination on anaerobic micro-organisms. Leone F; Morandotti MG; Mazzella P; Sanna A; Ravizzola G; Colombrita D; Pinzi G; Turano R; Menozzi MG; Lecchini R J Int Med Res; 1990; 18(3):191-200. PubMed ID: 2193834 [TBL] [Abstract][Full Text] [Related]
48. The effect of a combination of ampicillin and sulbactam against clinical isolates of anaerobic bacteria. Werner H; Heizmann W; Heilmann F Int J Antimicrob Agents; 1996 Apr; 6 Suppl():S27-30. PubMed ID: 18611716 [TBL] [Abstract][Full Text] [Related]